These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1700388)

  • 1. Combination of flecainide and mexiletine for the treatment of ventricular tachyarrhythmias.
    Jordaens LJ; Tavernier R; Vanmeerhaeghe X; Robbens E; Clement DL
    Pacing Clin Electrophysiol; 1990 Sep; 13(9):1127-35. PubMed ID: 1700388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation.
    Kim SG; Felder SD; Waspe LE; Fisher JD
    Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flecainide: long-term effects in patients with sustained ventricular tachycardia or ventricular fibrillation.
    van Wijk LM; Crijns HJ; Kingma HJ; van Gilst WH; van Gelder IC; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):884-91. PubMed ID: 1694910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
    Breithardt G; Seipel L; Abendroth RR
    J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
    Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
    Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL
    Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
    Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of combination therapy with amiodarone and type I agents for treatment of inducible ventricular tachycardia.
    Jung W; Mletzko R; Manz M; Nitsch J; Lüderitz B
    Pacing Clin Electrophysiol; 1993 Apr; 16(4 Pt 1):778-88. PubMed ID: 7683805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients.
    Waspe LE; Waxman HL; Buxton AE; Josephson ME
    Am J Cardiol; 1983 Apr; 51(7):1175-81. PubMed ID: 6340451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
    Capucci A; Di Pasquale G; Boriani G; Carini G; Balducelli M; Frabetti L; Carozzi A; Finzi A; Pinelli G; Magnani B
    Int J Clin Pharmacol Res; 1991; 11(1):23-33. PubMed ID: 1714885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of oral quinidine-mexiletine combination therapy for sustained ventricular tachyarrhythmias as assessed by programmed electrical stimulation when quinidine monotherapy has failed.
    Bonavita GJ; Pires LA; Wagshal AB; Cuello C; Mittleman RS; Greene TO; Huang SK
    Am Heart J; 1994 Apr; 127(4 Pt 1):847-51. PubMed ID: 8154423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation.
    Falk RH
    Ann Intern Med; 1989 Jul; 111(2):107-11. PubMed ID: 2500880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G; Bach P; Haberl R
    J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of combination drug therapy with a class IC antiarrhythmic agent and mexiletine for ventricular tachycardia.
    Mendes L; Podrid PJ; Fuchs T; Franklin S
    J Am Coll Cardiol; 1991 May; 17(6):1396-402. PubMed ID: 2016457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.
    Yeung-Lai-Wah JA; Murdock CJ; Boone J; Kerr CR
    J Am Coll Cardiol; 1992 Sep; 20(3):547-51. PubMed ID: 1512331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
    Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of mexiletine in patients with ventricular tachycardia.
    Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD
    Am Heart J; 1986 Jul; 112(1):14-9. PubMed ID: 3728269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inefficacy and proarrhythmic effects of flecainide and encainide for sustained ventricular tachycardia and ventricular fibrillation.
    Herre JM; Titus C; Oeff M; Eldar M; Franz MR; Griffin JC; Scheinman MM
    Ann Intern Med; 1990 Nov; 113(9):671-6. PubMed ID: 2121082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of mexiletine treatment in patients with recurrent ventricular tachyarrhythmias and implantable cardioverter-defibrillator shocks.
    Sobiech M; Lewandowski M; Zając D; Maciąg A; Syska P; Ateńska-Pawłowska J; Kowalik I; Sterliński M; Szwed H; Pytkowski M
    Kardiol Pol; 2017; 75(10):1027-1032. PubMed ID: 29057449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.